Interstitial cystitis/painful bladder syndrome: Epidemiology, pathophysiology and evidence-based treatment options

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 175, Issue 1, 2014, Pages 30-37

  Davis, N F ^a,b   Brady, C M ^b   Creagh, T ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

Interstitial cystitis; Interstitial cystitis painful bladder syndrome (IC PBS); Painful bladder syndrome

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN A; CAFFEINE; CHONDROITIN SULFATE; CYCLOSPORIN A; DIMETHYL SULFOXIDE; HYALURONIC ACID; HYDROXYZINE; NITRIC OXIDE; PENTOSAN POLYSULFATE; RESINFERATOXIN; TAMM HORSFALL GLYCOPROTEIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR AGONIST;

ALGORITHM; AUTOIMMUNITY; BLADDER TRAINING; CARBONATED BEVERAGE; CELL ACTIVATION; CONSERVATIVE TREATMENT; CYSTECTOMY; CYSTOSCOPY; DIET RESTRICTION; EVIDENCE BASED PRACTICE; FEMALE; FLUID INTAKE; GENETIC PREDISPOSITION; HUMAN; HYPERBARIC OXYGEN; INCIDENCE; INFLAMMATION; INTERSTITIAL CYSTITIS; MAST CELL; METABOLISM; MINIMALLY INVASIVE PROCEDURE; MYCOBACTERIUM BOVIS BCG; NEUROMODULATION; NON INVASIVE PROCEDURE; PATHOPHYSIOLOGY; PELVIC PAIN; PHYSICAL EXAMINATION; PLASTIC SURGERY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; TRANSURETHRAL RESECTION; URINARY DIVERSION; URINARY TRACT DISEASE; CYSTITIS, INTERSTITIAL; EVIDENCE BASED MEDICINE;

CYSTITIS, INTERSTITIAL; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 84898059473     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2013.12.041     Document Type: Review

References (44)

1. J.Q. Clemens, C.L. Link, and P.W. Eggers et al. Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women J Urol 177 2007 1390 1394
2. D.S. Engeler, A.P. Baranowski, and P. Dinis-Oliveira et al. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development Eur Urol 64 2013 431 439
3. M. Fall, A.P. Baranowski, and S. Elneil et al. EAU guidelines on chronic pelvic pain Eur Urol 57 2010 35 48
4. P.M. Hanno, D.A. Burks, and J.Q. Clemens et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome J Urol 185 2011 2162 2170
5. J.Q. Clemens, R.T. Meenan, M.C. Rosetti, S.Y. Gao, and E.A. Calhoun Prevalence and incidence of interstitial cystitis in a managed care population J Urol 173 2005 98 102 discussion
6. J.M. Park Is interstitial cystitis an underdiagnosed problem in children? A diagnostic and therapeutic dilemma Urology 57 6 Suppl 1 2001 30 31
7. N.F. Davis, N. Breslin, and T. Creagh Using google trends to assess global interest in 'dysport(R)' for the treatment of overactive bladder Urology 82 2013 1189
8. N.F. Davis, L.G. Smyth, and H.D. Flood Detecting internet activity for erectile dysfunction using search engine query data in the Republic of Ireland BJU Int 110 2012 E939 E942
9. S. Keay, F. Seillier-Moiseiwitsch, C.O. Zhang, T.C. Chai, and J. Zhang Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment Physiol Genomics 14 2003 107 115
10. M. Vij, S. Srikrishna, and L. Cardozo Interstitial cystitis: diagnosis and management Eur J Obstet Gynecol Reprod Biol 161 2012 1 7
11. N.F. Davis, B.B. McGuire, A. Callanan, H.D. Flood, and T.M. McGloughlin Xenogenic extracellular matrices as potential biomaterials for interposition grafting in urological surgery J Urol 184 2010 2246 2253
12. C.L. Parsons The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis Urology 69 4 Suppl 2007 9 16
13. V.B. Lokeshwar, M.G. Selzer, and W.H. Cerwinka et al. Urinary uronate and sulfated glycosaminoglycan levels: markers for interstitial cystitis severity J Urol 174 2005 344 349
14. S.D. Smith, M.A. Wheeler, H.E. Foster Jr., and R.M. Weiss Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections J Urol 155 1996 1432 1435
15. M.R. Silk Bladder antibodies in interstitial cystitis J Urol 103 1970 307 309
16. J.W. Warren, T.L. Jackson, P. Langenberg, D.J. Meyers, and J. Xu Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis Urology 63 2004 17 21
17. D.P. Lubeck, K. Whitmore, G.R. Sant, S. Alvarez-Horine, and C. Lai Psychometric validation of the O'leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium Urology 57 6 Suppl 1 2001 62 66
18. J.P. van de Merwe, J. Nordling, and P. Bouchelouche et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal Eur Urol 53 2008 60 67
19. S.G. Mulholland, P. Hanno, C.L. Parsons, G.R. Sant, and D.R. Staskin Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study Urology 35 1990 552 558
20. J.C. Nickel, J. Barkin, and J. Forrest et al. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis Urology 65 2005 654 658
21. A. van Ophoven, S. Pokupic, A. Heinecke, and L. Hertle A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis J Urol 172 2004 533 536
22. J. Sairanen, T.L. Tammela, and M. Leppilahti et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study J Urol 174 2005 2235 2238
23. G.R. Sant, K.J. Propert, and P.M. Hanno et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis J Urol 170 2003 810 815
24. R. Thilagarajah, R.O. Witherow, and M.M. Walker Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial BJU Int 87 2001 207 212
25. G.R. Sant, and D.R. LaRock Standard intravesical therapies for interstitial cystitis Urol Clin North Am 21 1994 73 83
26. R. Perez-Marrero, L.E. Emerson, and J.T. Feltis A controlled study of dimethyl sulfoxide in interstitial cystitis J Urol 140 1988 36 39
27. G. Steinhoff, B. Ittah, and S. Rowan The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis Can J Urol 9 2002 1454 1458
28. J.C. Nickel, R.B. Egerdie, G. Steinhoff, B. Palmer, and P. Hanno A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome Urology 76 2010 804 809
29. R. Peeker, M.A. Haghsheno, S. Holmang, and M. Fall Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study J Urol 164 2000 1912 1915 discussion 5-6
30. C.R. Riedl, P.F. Engelhardt, K.L. Daha, N. Morakis, and H. Pfluger Hyaluronan treatment of interstitial cystitis/painful bladder syndrome Int Urogynecol J Pelvic Floor Dysfunct 19 2008 717 721
31. A. Morales, L. Emerson, and J.C. Nickel Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis Urology 49 5A Suppl 1997 111 113
32. I. Ahmad Sarath Krishna N, Meddings RN. Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study Int Urogynecol J Pelvic Floor Dysfunct 19 2008 543 546
33. A. Apostolidis, G.E. Gonzales, and C.J. Fowler Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation Eur Urol 50 2006 1299 1305
34. C.K. Payne, P.G. Mosbaugh, and J.B. Forrest et al. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial J Urol 173 2005 1590 1594
35. R. Pinto, T. Lopes, and B. Frias et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis Eur Urol 58 2010 360 365
36. N. Zabihi, A. Mourtzinos, M.G. Maher, S. Raz, and L.V. Rodriguez Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain Int Urogynecol J Pelvic Floor Dysfunct 19 2008 553 557
37. Y.Q. Ghazwani, M.S. Elkelini, and M.M. Hassouna Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: long-term follow-up Neurourol Urodyn 30 2011 1271 1275
38. A. van Ophoven, G. Rossbach, F. Pajonk, and L. Hertle Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial J Urol 176 2006 1442 1446
39. E. Greenberg, R. Barnes, S. Stewart, and T. Furnish Transurethral resection of Hunner's ulcer J Urol 111 1974 764 766
40. R. Peeker, F. Aldenborg, and M. Fall Complete transurethral resection of ulcers in classic interstitial cystitis Int Urogynecol J Pelvic Floor Dysfunct 11 2000 290 295
41. A. van Ophoven, F. Oberpenning, and L. Hertle Long-term results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis J Urol 167 2002 603 607
42. J.G. Blaivas, J.P. Weiss, P. Desai, A.J. Flisser, D.S. Stember, and P.J. Stahl Long-term followup of augmentation enterocystoplasty and continent diversion in patients with benign disease J Urol 173 2005 1631 1634
43. M. Fall, F. Oberpenning, and R. Peeker Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions Eur Urol 54 2008 65 75
44. B.G. Volkmer, J.E. Gschwend, K. Herkommer, J. Simon, R. Kufer, and R.E. Hautmann Cystectomy and orthotopic ileal neobladder: the impact on female sexuality J Urol 172 2004 2353 2357